Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atrial fibrillation and obstructive lung disease: Don't fear the β-blocker.

Literature DB >> 30031909

Atrial fibrillation and obstructive lung disease: Don't fear the β-blocker.

Zak Loring¹, Jonathan P Piccini².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2018 PMID： 30031909 PMCID： PMC6354245 DOI： 10.1016/j.hrthm.2018.07.023

Source DB: PubMed Journal: Heart Rhythm ISSN： 1547-5271 Impact factor: 6.343

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.

Authors: R S MCNEILL
Journal: Lancet Date: 1964-11-21 Impact factor: 79.321

2. Lenient versus strict rate control in patients with atrial fibrillation.

Authors: Isabelle C Van Gelder; Hessel F Groenveld; Harry J G M Crijns; Ype S Tuininga; Jan G P Tijssen; A Marco Alings; Hans L Hillege; Johanna A Bergsma-Kadijk; Jan H Cornel; Otto Kamp; Raymond Tukkie; Hans A Bosker; Dirk J Van Veldhuisen; Maarten P Van den Berg
Journal: N Engl J Med Date: 2010-03-15 Impact factor: 91.245

Review 3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal: J Am Coll Cardiol Date: 2014-03-28 Impact factor: 24.094

4. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.

Authors: Michael T Durheim; DaJuanicia N Holmes; Rosalia G Blanco; Larry A Allen; Paul S Chan; James V Freeman; Gregg C Fonarow; Alan S Go; Elaine M Hylek; Kenneth W Mahaffey; Sean D Pokorney; James A Reiffel; Daniel E Singer; Eric D Peterson; Jonathan P Piccini
Journal: Heart Date: 2018-06-06 Impact factor: 5.994

5. Rate-control treatment and mortality in atrial fibrillation.

Authors: Tze-Fan Chao; Chia-Jen Liu; Ta-Chuan Tuan; Su-Jung Chen; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Tzeng-Ji Chen; Chern-En Chiang; Shih-Ann Chen
Journal: Circulation Date: 2015-09-17 Impact factor: 29.690

6. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors: Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal: Circulation Date: 2013-12-17 Impact factor: 29.690

7. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

Authors: Brian Olshansky; Lynda E Rosenfeld; Alberta L Warner; Allen J Solomon; Gearoid O'Neill; Arjun Sharma; Edward Platia; Gregory K Feld; Toshio Akiyama; Michael A Brodsky; H Leon Greene
Journal: J Am Coll Cardiol Date: 2004-04-07 Impact factor: 24.094